```html

Kleine‑Levin Syndrome (Episodes of Hyperphagia)

What is Kleine‑Levin Syndrome (Episodes of Hyperphagia)?

Kleine‑Levin Syndrome (KLS) is a rare neurological disorder characterized by recurrent episodes of extreme sleepiness (hypersomnia) and compulsive overeating (hyperphagia). During an episode, a person may sleep up to 20 hours a day, feel a powerful craving for food, and exhibit behavioral changes such as irritability or confusion. Between episodes, individuals typically return to a normal baseline of cognition, mood, and sleep patterns.

The condition was first described by Swiss physicians Max Kleine and Max Levin in 1925, and it remains one of the most poorly understood sleep‑wake disorders. The prevalence is estimated at 1–5 cases per million people, with a strong male predominance (about 70% of reported cases) and onset most often in adolescence (average age 15‑16 years) <sup>[1][2]</sup>.

Common Causes

The exact cause of KLS is unknown, but several factors have been implicated. The following conditions or triggers are reported in the literature as potentially precipitating an episode or increasing the risk of developing KLS:

• Idiopathic (unknown) origin – most cases have no identifiable trigger.
• Post‑viral infection – influenza, Epstein‑Barr virus, or other viral illnesses can precede the first episode.
• Traumatic brain injury – especially lesions involving the hypothalamus or thalamus.
• Autoimmune processes – antibodies against neuronal tissue have been detected in a minority of patients.
• Genetic predisposition – families with multiple affected members suggest a heritable component.
• Sleep‑wake cycle disturbances – irregular sleep patterns or shift work may act as a trigger.
• Psychotropic medication changes – abrupt withdrawal of stimulants or antidepressants has been reported.
• Metabolic abnormalities – rare cases linked to hypothyroidism or hyperprolactinemia.
• Neurodegenerative disease – very rare, but an underlying progressive disorder can mimic KLS.
• Psychological stress – intense emotional stress may precipitate an episode, though causality is unclear.

Associated Symptoms

While hyperphagia and hypersomnia are the hallmark features, most patients experience a cluster of additional symptoms during an episode:

• Behavioural changes – irritability, aggressiveness, or emotional lability.
• Cognitive impairment – difficulty concentrating, memory lapses, and slowed thinking (“brain fog”).
• Sexual disinhibition – increased libido or inappropriate sexual behaviour (more common in males).
• Hallucinations or delusions – visual, auditory, or tactile, usually mild.
• Autonomic signs – excessive thirst, sweating, or temperature dysregulation.
• Weight gain – rapid increase due to compulsive eating, often with a preference for high‑carbohydrate foods.
• Depressive or anxious mood – feelings of hopelessness or panic during or after an episode.
• Motor restlessness – pacing, fidgeting, or inability to stay still.

When to See a Doctor

Because KLS can mimic psychiatric disorders, metabolic disease, or other sleep‑wake conditions, early professional evaluation is essential. Seek medical care if you or a loved one experiences:

• Unexplained prolonged sleep (≥18 hours per day) lasting more than a few days.
• Sudden, intense cravings for food accompanied by rapid weight gain.
• Marked changes in mood, cognition, or behaviour that interfere with school, work, or relationships.
• Episodes that recur at irregular intervals (often every 2‑12 weeks).
• Any neurological symptoms such as headaches, visual disturbances, or weakness.
• Signs of dehydration, severe electrolyte imbalance, or rapid deterioration in mental status (see Emergency Warning Signs below).

Diagnosis

Diagnosing KLS is primarily a clinical process, as no single laboratory test confirms the disorder. The typical diagnostic pathway includes:

1. Detailed medical history

• Timeline of episodes (duration, frequency, prodrome).
• Associated triggers (infection, trauma, medication changes).
• Family history of sleep or psychiatric disorders.

2. Physical and neurologic examination

• Assessment of weight, vital signs, and signs of dehydration.
• Neurologic screen to rule out focal deficits.

3. Sleep studies

• Polysomnography (PSG) – records brain waves, eye movements, and muscle tone; often normal or shows non‑specific findings in KLS.
• Multiple Sleep Latency Test (MSLT) – measures how quickly a person falls asleep; typically shows extremely short sleep latency during episodes.

4. Neuroimaging

• MRI of the brain is performed to exclude structural lesions; some studies reveal transient hypoperfusion in the thalamus or hypothalamus during episodes.

5. Laboratory work‑up

• Basic metabolic panel, thyroid function tests, and inflammatory markers to rule out metabolic or infectious causes.
• In selected cases, autoimmune panels or cerebrospinal fluid analysis may be ordered.

6. Diagnostic criteria

Most clinicians use the International Classification of Sleep Disorders (ICSD‑3) criteria, which require:

1. Recurrent episodes of hypersomnia lasting weeks to months.
2. At least one of the following: hyperphagia, hypersexuality, or behavioral/cognitive disturbances.
3. Complete return to baseline functioning between episodes.
4. Absence of another medical or psychiatric disorder that better explains the symptoms.

Treatment Options

There is no cure for KLS, but several strategies can shorten episode duration, lessen severity, and improve quality of life.

Pharmacologic therapies

• Stimulants (e.g., modafinil, methylphenidate) – help reduce daytime sleepiness and improve alertness.
• Antidepressants (tricyclics or SSRIs) – may alleviate mood disturbances and, in some reports, reduce episode frequency.
• Low‑dose antipsychotics – occasionally used for severe behavioral dysregulation.
• Orexin‑receptor antagonists – emerging evidence suggests possible benefit, but data remain limited.
• Immunomodulatory agents (corticosteroids, IVIG) – tried in patients with suspected autoimmune etiology, with mixed results.

Non‑pharmacologic approaches

• Sleep‑hygiene education – maintain consistent bedtime/wake time, limit napping, and create a dark, quiet sleeping environment.
• Structured meals – plan regular, balanced meals; use portion control to avoid extreme caloric excess.
• Behavioral therapy – cognitive‑behavioral therapy (CBT) can help patients cope with mood swings and develop healthier coping mechanisms.
• Hydration and electrolyte monitoring – especially important during episodes of excessive eating and possible vomiting.
• Support groups – connecting with other families affected by KLS can reduce isolation and share practical tips.

Long‑term management

Most patients experience a gradual decline in episode frequency and severity over several years, often entering remission in their late twenties or early thirties. Regular follow‑up with a neurologist or sleep‑medicine specialist is advised to adjust therapies and monitor for comorbidities such as depression or obesity.

Prevention Tips

Because KLS is largely idiopathic, absolute prevention is not possible, but the following measures may reduce trigger exposure and lessen episode severity:

• Prompt treatment of infections – seek medical care for fevers, sore throats, or viral illnesses.
• Avoid head trauma – wear helmets during high‑risk activities (cycling, skateboarding, contact sports).
• Maintain regular sleep patterns – aim for 7‑9 hours of sleep nightly, even on weekends.
• Limit stimulant withdrawal – taper any caffeine, nicotine, or prescription stimulants under physician supervision.
• Monitor stress levels – incorporate relaxation techniques such as mindfulness, yoga, or deep‑breathing exercises.
• Healthy diet – balanced macronutrients help prevent extreme cravings; consider consulting a dietician familiar with KLS.
• Vaccinations – stay up‑to‑date on flu and other recommended vaccines to lower viral trigger risk.

Emergency Warning Signs

---

References:
[1] American Academy of Sleep Medicine. “International Classification of Sleep Disorders, 3rd ed.” 2014.
[2] Herskovits, E. et al. “Kleine‑Levin syndrome: clinical features, neuroimaging, and management.” Neurology, 2020.
[3] Mayo Clinic. “Kleine‑Levin syndrome.” Accessed March 2024.
[4] National Institutes of Health, National Institute of Neurological Disorders and Stroke. “Kleine‑Levin syndrome fact sheet.” 2023.
[5] World Health Organization. “Guidelines for the management of rare neurological disorders.” 2022.

```